• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Pharma & Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Events
  • Advertise

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

Editor’s Choice

  • Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
    August 10, 2020
  • The integral role of the microbiome in a post-pandemic world
    August 10, 2020

Latest Headlines

New live biotherapeutics will require regulatory and scientific innovation: The importance of a defined regulatory framework

  • A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist

  • Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results

  • LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial for the Treatment of Obesity and Metabolic Diseases

  • Researchers receive $3 million NSF grant to ‘understand the rules of life’ through microbiome research.

  • New live biotherapeutics will require regulatory and scientific innovation: The importance of a defined regulatory framework
  • A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist
  • Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results
  • LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial for the Treatment of Obesity and Metabolic Diseases
  • Researchers receive $3 million NSF grant to ‘understand the rules of life’ through microbiome research.
  • BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for IBD
4D Pharma animal microbiome cancer Cholestoral chr hansen Cosmos ID DuPont IBD Industry Academia Industry Academic Partnerships innovation Live Biotherapeutics microbiome Microbiotica Optibiotix phage probiotics Strategic Collaboration synlogic Synthetic Biologics
No comments found
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Pharma & Human Health
  • Phytobiome & Environment
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletterÂ